OR WAIT null SECS
February 07, 2022
The acquisition will include Rewrite’s DNA writing platform, expanding Intellia’s genome editing tools.
January 05, 2022
With this investment into Yapan Bio, Piramal Pharma adds new technologies and capabilities in large molecules, including vaccines and gene therapies, to its global offering.
December 17, 2021
Genezen has opened its new process development and analytical lab for viral vector production.
December 16, 2021
Pfizer invested $68.5 million in a facility in Durham, NC.
December 13, 2021
SKAN’s new Cellana isolator is designed for GMP manufacturing of ATMPs.
December 10, 2021
Guide addresses challenges of applying GMPs to autologous cell therapy manufacturing.
December 09, 2021
A new Cytiva FlexFactory platform will be installed at Taiyo Pharma Tech’s site in Osaka, Japan.
December 01, 2021
Analytical methods need a boost to ensure quality control for cell and gene therapies.
November 10, 2021
Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.
November 08, 2021
Part 1—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius discuss key issues affecting the development of emerging biotherapies.